Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Mizuho 

Quest Diagnostics Inc. diskutieren

Quest Diagnostics Inc.

WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Aktie / Anbieter & Dienstleistungen / Large Cap /

200,50 €
1,30 %

8 0
8
0

Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Jefferies Financial Group Inc. 
0
Melden Teilen
21.10.25 Buy 25,98 %

Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Ratings data for DGX provided by MarketBeat

SVB Leerink LLC 
0
Melden Teilen
21.10.25 Buy 25,98 %

Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Jefferies Financial Group Inc. 
0
Melden Teilen
10.02.26 Buy 16,20 %

Quest Diagnostics (DGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Jefferies Financial Group Inc. 
0
Melden Teilen
21.04.26 Buy 14,57 %
Einschätzung Buy
Rendite (%) 15,10 %
Kursziel 195,85
Veränderung
Endet am 22.04.27

Quest Diagnostics (DGX) had its price target raised by Barclays PLC from $225.00 to $230.00. They now have an "overweight" rating on the stock.
Ratings data for DGX provided by MarketBeat

Barclays PLC 
0
Melden Teilen
22.04.26

Quest Diagnostics (DGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Jefferies Financial Group Inc. 
0
Melden Teilen
23.07.26 Buy 0,15 %

Quest Diagnostics (DGX) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for DGX provided by MarketBeat

Barclays PLC 
0
Melden Teilen
23.07.26 Buy 0,05 %

Thanks for sharing such an informative post 👍https://fawanewssc.com/

fawanews 
0
Melden Teilen
09:18
Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 228,49
Veränderung
Endet am 24.07.27

Quest Diagnostics (DGX) had its price target raised by Mizuho from $235.00 to $260.00. They now have an "outperform" rating on the stock.
Ratings data for DGX provided by MarketBeat

Mizuho 
0
Melden Teilen
21:00
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Citigroup_Inc_ in Union Pacific Corp. diskutieren
Union Pacific (UNP) had its price target raised by Citigr...
21:30
Citigroup_Inc_ in Honeywell International diskutieren
Honeywell International (HON) had its price target raised...
21:30
Citigroup_Inc_ in Crown Castle Internatl Corp. diskutieren
Crown Castle (CCI) had its price target lowered by Citigr...
21:00
Citigroup_Inc_ in International Business Machines Corp diskutieren
International Business Machines (IBM) had its price targe...
21:00
Mizuho in Quest Diagnostics Inc. diskutieren
Quest Diagnostics (DGX) had its price target raised by Mi...
21:00
JPMorgan_Chase___Co_ in Valley National Bancorp diskutieren
Valley National Bancorp (VLY) had its price target lowere...
20:45
JPMorgan_Chase___Co_ in Southwest Airlines Co. diskutieren
Southwest Airlines (LUV) had its price target lowered by ...
20:45
BMO_Capital_Markets in Southwest Airlines Co. diskutieren
Southwest Airlines (LUV) had its price target raised by B...
20:45
Mehr anzeigen